Citation Impact
Citing Papers
Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma
2005 Standout
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
2000 Standout
Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate
1992
Herpes Simplex Virus Types 1 and 2 Differ in Their Interaction with Heparan Sulfate
2000
Heparin-Protein Interactions
2002 Standout
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
2010 Standout
Marine natural products
1990 Standout
Drug development from marine natural products
2008 Standout
A Case of Zoster in the 2nd and 3rd Branches of the Trigeminal Nerve Associated with Simultaneous Herpes Labialis Infection. A Case Report.
1997
Effects of an Interferon Inducer Bropirimine on Bleomycin‐Induced Lung Fibrosis in Hamsters*
1992
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Determinants for Membrane Association of the Hepatitis C Virus RNA-dependent RNA Polymerase
2001 StandoutNobel
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
2007 Standout
Optimal two-stage designs for phase II clinical trials
1989 Standout
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield
1999 Standout
Stress-induced immune dysfunction: implications for health
2005 Standout
Selective Rearrangements of Quadruply Hydrogen‐Bonded Dimer Driven by Donor–Acceptor Interaction
2003
Modern Synthetic Methods for Fluorine‐Substituted Target Molecules
2004 Standout
Natural products as probes of cell biology: 20 years of didemnin research
2002
Nmr in drug discovery
2002 StandoutNobel
Exact repeated confidence intervals for Bernoulli parameters in a group sequential clinical trial
1993
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
PRODUCTION AND ROLE OF INTERFERON IN PHYSIOLOGICAL CONDITIONS
1981
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
2009 Standout
Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration
1989
Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells
1987
Improved synthesis of 1,5-dinaphtho[38]crown-10
2009 StandoutNobel
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
2009 StandoutScience
Supramolecular Polymerization
2009 Standout
Activation of B lymphocytes by locally concentrated concanavalin A
1972 StandoutNobel
Novel Inhibitors of Erm Methyltransferases from NMR and Parallel Synthesis
1999
Predictive Probability Early Termination Plans For Phase II Clinical Trials
1979
Mechanisms of herpes simplex virus type 1 reactivation
1996
An overview of the role of nucleosides in chemotherapy
1985 StandoutNobel
Interval Estimation for a Binomial Proportion
2001 Standout
Confidence Intervals for a Binomial Parameter Following a Multistage Test With Application to MIL-STD 105D and Medical Trials
1983
Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach
2020 Standout
The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry
2007 Standout
Roles of Infectious Agents in Atherosclerosis and Restenosis
1997 Standout
Differential effects of nerve growth factor and dexamethasone on herpes simplex virus type 1 oriL- and oriS-dependent DNA replication in PC12 cells
1997
An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
2020 Standout
Pathogenetic mechanisms of recurrent herpes simplex virus infections
1976
Structure−Activity Relationships in Human Toll-Like Receptor 7-Active Imidazoquinoline Analogues
2010
The Regulatory Influence of Activated T Cells on B Cell Responses to Antigen
1972 StandoutNobel
Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine.
1978 StandoutNobel
Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions
1998 Standout
Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate
1979 StandoutNobel
The discovery of marine natural products with therapeutic potential.
1994
The Us9 Gene Product of Pseudorabies Virus, an Alphaherpesvirus, Is a Phosphorylated, Tail-Anchored Type II Membrane Protein
1998
Natural Products in Drug Discovery and Development
1997 Standout
Effect of Acycloguanosine Treatment on Acute and Latent Herpes Simplex Infections in Mice
1979 StandoutNobel
Treatment of mice with polyinosinic-polycytidilic polyribonucleotide reduces T-cell involvement in a localized inflammatory response to vaccinia virus challenge
1985 StandoutNobel
A Historical Overview of Natural Products in Drug Discovery
2012 Standout
The Immune Response in Tuberculosis
2013 Standout
Synthesis of 1‐(2‐deoxy‐2‐fluoro‐β‐D‐arabinofuranosyl)‐5‐iodo [2‐14C] uracil
1985
One-Sample Multiple Testing Procedure for Phase II Clinical Trials
1982 Standout
Antiviral Activity of Arabinosylthymine in Herpesviral Replication: Mechanism of Action In Vivo and In Vitro
1977
Tetrahedron report number 163
1984 Standout
Evaluation of interferon and interferon inducers as antiviral agents: Animal studies
1981
Central nervous system infection and immune response in mice inoculated into the lip with herpes simplex virus type 1
1982 StandoutNobel
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Group Sequential Designs for Clinical Trials
1973
Unstressing intemperate models: how cold stress undermines mouse modeling
2012
Pseudorabies virus envelope glycoproteins gp50 and gII are essential for virus penetration, but only gII is involved in membrane fusion
1992
Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine
1977 StandoutNobel
INDUCTION OF A HEMOLYSIN RESPONSE IN VITRO
1970
Group sequential methods in the design and analysis of clinical trials
1977 Standout
Isolation of virus from brain after immunosuppression of mice with latent herpes simplex
1981 StandoutNatureNobel
Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities
1981 StandoutNobel
Protein kinase in human plasma analogous to that present in control and interferon-treated HeLa cells
1981 StandoutNobel
Self-assembly of a new series of quadruply hydrogen bonded heterotrimers driven by the donor–acceptor interaction
2005
In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)
2020
Inhibition of herpes simplex virus replication by araT
1975
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
2005 Standout
Antiviral agents as adjuncts in cancer chemotherapy
1980
Methods for the synthesis of gem-difluoromethylene compounds
1996
Works of Sheldon D. Weed being referenced
Comparison between Circulating Interferon and Drug Levels Following Administration of 2-amino-5-bromo-6-phenyl-4(3H)-Pyrimidinone (ABPP) to Different Animal Species
1982
Protective Effect of Elevated Temperature on Mice Infected with Coe Virus
1966
Efficacy of N6-(2-Hydroxyethyl)Adenine Against Coe Virus Infection In Mice
1966
Pyrimidinones. 1. 2-Amino-5-halo-6-aryl-4(3H)-pyrimidinones. Interferon-inducing antiviral agents
1985
Stimulation of Murine Interferon by a Substituted Pyrimidine
1976
Antiviral and Interferon-Inducing Properties of 1,5-Diamino Anthraquinones
1979
Cytosine Arabinoside (CA) and Other Nucleosides in Herpes Virus Infections
1964
Didemnins A and B. Effectiveness against cutaneous herpes simplex virus in mice
1983
Recurrent Cutaneous Herpes Simplex in Hairless Mice
1974
The pseudorabies virus gII gene is closely related to the gB glycoprotein gene of herpes simplex virus
1987
Multiple-Stage Procedures for Drug Screening
1973
5-Substituted 2-amino-6-phenyl-4(3H)-pyrimidinones. Antiviral- and interferon-inducing agents
1980